Elevance Health Inc. (ELV) Misses Q3 EPS by $1.29, Beats on Revenue

Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $8.37, $1.29 worse than the analyst estimate of $9.66. Revenue for the quarter came in at $44.7 billion versus the consensus estimate of $43.46 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• Silver Lake In Talks To Buy Workday, Sources Say - Reuters
• Workday stock surges on Silver Lake buyout talks report
• Omega Flex (OFLX) Tops Q2 EPS by 27c